Search Results for "Erythromycin Ophthalmic Ointment Usp 0 5"
Matching Channels
Veregen® is an ointment used to treat external genital warts. In the USA, Germany, Austria, Spain, Switzerland and Serbia, Veregen® is already marketed by our partners. Sales and marketing p...
Trigeminal Neuralgia (TN) is an extremely severe facial pain that tends to come and go unpredictably in sudden shock-like attacks. The pain is often described as stabbing, shooting, excruciating, bu...
Tumor Necrosis Factor TNF Products
Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...
Cytokine Tumour Necrosis Factor (TNF)
TNF is a compound that is classified as a cytokine which plays a central role in the cellular mechanisms of apoptosis or cell death. However, there are a number of different kinds of TNF, just under...
Matching News
Perrigo acquires ophthalmic portfolio from Fera Pharma for initial $93 million
Generic drugmaker Perrigo (NYSE: PRGO) says it has signed a definitive agreement to acquire and has completed the acquisition of an ophthalmic sterile ointment and solution Abbreviated New Drug Applic...
Erythromycin may provide benefit for patients with non-CF bronchiectasis
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resis...
ImportanceMacrolide antibiotics such as erythromycin may improve clinical outcomes in non–cystic fibrosis (CF) bronchiectasis, although associated risks of macrolide resistance are poorly defined.Ob...
Perrigo Acquires Eye-Care Portfolio from Fera
Perrigo Co. said Monday that it bought the ophthalmic ointment and solution portfolio of Fera Pharmaceuticals LLC for $93 million in cash. Perrigo has been looking for an ophthalmic deal as part of it...
Using Soap & Ointment on ICU Patients Reduces Infections, CDC Says
A new study on antibiotic-resistant bacteria in hospitals shows that using germ-killing soap and ointment on all intensive-care unit (ICU) patients can reduce bloodstream infections by up t...
Allergan Inks Two More Deals With Molecular Partners On New Approach To Ophthalmic Conditions
Allergan licenses a second novel product from Switzerland's Molecular Partners for ophthalmic indications and enters into a discovery alliance under which it has the option to license three further op...
NAD Refers Summers Labs Ointment Claim To FTC After J&J Challenge
Claims for Summers Labs’ Triple Paste diaper rash ointment spurred Desitin maker Johnson & Johnson to bring a challenge through the National Advertising Division. Summers disagreed with NAD’s...
Genetic mechanisms of variation in erythromycin resistance in Lactobacillus rhamnosus strains
Matching PubMed Articles
In vivo effects of adjunctive tetracycline treatment on refractory corneal ulcers in dogs.
Objective-To evaluate effect of adjunctive treatment with tetracycline analogues on time to complete corneal reepithelialization in dogs with nonhealing (ie, refractory) corneal ulcers. Design-Randomi...
Background: The purpose of this study is to conduct a histopathological research of the conjunctival findings and eosinophilic inflammation of novel atopic keratoconjunctivitis in a NC/Nga mouse model...
The two-compound ointment (Taclonex/Daivobet/Dovobet ointment) combining calcipotriene 50 microg/g and betamethasone 0.5 mg/g (as dipropionate) is very effective in the treatment of psoriasis vulgaris...
Homogeneity study of ointment dosage forms by infrared imaging spectroscopy.
Ointment dosage forms are semi-solid preparations intended for local or transdermal delivery of active substances usually for application to the skin and it is important that they present a homogeneou...
Loteprednol etabonate ophthalmic gel 0.5 % (Lotemax(®)) is approved in the USA for the treatment of post-operative inflammation and pain in patients who have undergone ocular surgery. The new gel fo...